InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,069.20
(
0.15%
)
US TECH 100
17,258.40
(
0.09%
)
Dow Jones
37,899.63
(
0.44%
)
Brent Oil
89.68
(
-0.22%
)
Bitcoin
63,064.10
(
-0.57%
)
Post# of 18784
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investwisely123

Send PM Follow Ignore
Followers 1
Posts 36
Boards Moderated 0
Alias Born 11/16/2018

Investwisely123

Re: None

Wednesday, 12/26/2018 8:51:25 AM

Wednesday, December 26, 2018 8:51:25 AM

Post# of 18784
AEZS's drug Macrilen is the safest, most effective, most reliable, most accurate and easiest to use test for diagnosing adult growth hormone deficiency (AGHD) and is the only FDA approved drug for diagnosing AGHD. Macrilen should very soon be approved in Europe next month.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AEZS News
More AEZS News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • Apr 16, 2024 8:52 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM

Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM

Avant Technologies Begins Development on Next-Generation AI-Driven Resource Allocation Solution • AVAI • Apr 16, 2024 8:00 AM

UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!